Anderson, A. N.
, Pavese, N., Edison, P., Tai, Y. F., Hammers, A., Gerhard, A.
, Brooks, D. J. & Turkheimer, F. E. (2007).
A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
NeuroImage,
36(1), 28-37.
https://doi.org/10.1016/j.neuroimage.2007.02.017
Hammers, A., Asselin, M. C., Turkheimer, F. E., Hinz, R., Osman, S., Hotton, G.
, Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007).
Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data.
NeuroImage,
38(1), 82-94.
https://doi.org/10.1016/j.neuroimage.2007.06.035
Williams, T. M., Daglish, M. R. C., Lingford-Hughes, A., Taylor, L. G., Hammers, A.
, Brooks, D. J., Grasby, P., Myles, J. S. & Nutt, D. J. (2007).
Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study.
British Journal of Psychiatry,
191(JULY), 63-69.
https://doi.org/10.1192/bjp.bp.106.031120
Mínguez-Castellanos, A., Escamilla-Sevilla, F., Hotton, G. R., Toledo-Aral, J. J., Ortega-Moreno, Á., Méndez-Ferrer, S., Martín-Linares, J. M., Katati, M. J., Mir, P., Villadiego, J., Meersmans, M., Pérez-García, M.
, Brooks, D. J., Arjona, V. & López-Barneo, J. (2007).
Carotid body autotransplantation in Parkinson disease: A clinical and positron emission tomography study.
Journal of Neurology, Neurosurgery & Psychiatry,
78(8), 825-831.
https://doi.org/10.1136/jnnp.2006.106021
Tai, Y. F., Ahsan, R. L., De Yébenes, J. G.
, Pavese, N., Brooks, D. J. & Piccini, P. (2007).
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An 18F-dopa PET study.
Journal of Neural Transmission,
114(3), 337-340.
https://doi.org/10.1007/s00702-006-0536-0
Turner, M. R., Rabiner, E. A., Al-Chalabi, A., Shaw, C. E.
, Brooks, D. J., Leigh, P. N.
& Andersen, P. M. (2007).
Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
Neurology,
68(15), 1233-1235.
https://doi.org/10.1212/01.wnl.0000259083.31837.64
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2007).
Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET. In
Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET (8 ed., Vol. 254, pp. 1033-1036)
https://doi.org/10.1007/s00415-006-0482-7
Lippa, C. F.
, Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F.
, Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., Fahn, S., Farmer, J. M., Galasko, D., Galvin, J. E., Goetz, C. G., Growdon, J. H., Gwinn-Hardy, K. A., Hardy, J., Heutink, P. ... Wszolek, Z. K. (2007).
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers.
Neurology,
68(11), 812-819.
https://doi.org/10.1212/01.wnl.0000256715.13907.d3
Pitkänen, A., Mathiesen, C., Rønn, L. C. B.
, Møller, A. & Nissinen, J. (2007).
Effect of novel AMPA antagonist, NS 1209, on status epilepticus, an experimental study in rat.
Epilepsy Research, (3780), 1-10.
Landau, A. M., Olsen, A. K., Wegener, G., Videbech, P., Gjedde, A. & Doudet, D. (2007).
Evaluation of the role of monoamines in electroconvulsive therapy in an animal model of Parkinsons Disease - a project proposal. Abstract from Forskningens Dag, Århus, Denmark.
Thomsen, K. R., Peterson, E.
, Doudet, D., Gjedde, A., Møller, A. & Linnet, J. (2007).
Gambling as Self-medication? - Preliminary results on Dopamine and Depression in Pathological Gambling. In
Sixth Annual OAK Meeting for Danish Laboratories
Tai, Y. F.
, Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2007).
Imaging microglial activation in Huntington's disease.
Brain Research Bulletin,
72(2-3 SPEC. ISS.), 148-151.
https://doi.org/10.1016/j.brainresbull.2006.10.029
Tomasi, G., Bertoldo, A., Edison, P., Roncaroli, F.
, Pavese, N., Hammers, A., Yen, F. T., Cobelli, C.
, Brooks, D. J., Gerhard, A. & Turkheimer, F. (2007).
Increased binding potential of [11C]PK11195 in Alzheimer disease using a new SRTM accounting for vascular binding.
Journal of Cerebral Blood Flow and Metabolism,
27(SUPPL. 1).
Pedersen, K., Simonsen, M.
, Østergaard, S. D., Munk, O. L., Rosa-Neto, P., Olsen, A. K.
, Jensen, S. B., Møller, A. & Cumming, P. (2007).
Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition.
NeuroImage,
35(1), 38-46.
https://doi.org/10.1016/j.neuroimage.2006.11.038
Tai, Y. F.
, Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2007).
Microglial activation in presymptomatic Huntington's disease gene carriers.
Brain,
130(7), 1759-1766.
https://doi.org/10.1093/brain/awm044
Turkheimer, F. E., Anderson, A. N., Boussion, N.
, Pavese, N., Brooks, D. J. & Visvikis, D. (2007).
PET image denoising through a synergistic wavelet transform based multi-resolution analysis of structural and functional datasets.
Journal of Cerebral Blood Flow and Metabolism,
27(SUPPL. 1).
Turkheimer, F. E., Edison, P.
, Pavese, N., Roncaroli, F., Anderson, A. N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y. F.
& Brooks, D. J. (2007).
Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
Journal of Nuclear Medicine,
48(1), 158-167.
Nahimi, A.
, Olsen, A. K., Møller, A., Jakobsen, S., Østergaard, S. D.
& Doudet, D. (2007).
Role of monoaminergic innervation in 6-hydroxydopamine unilateral lesioned animal model of Parkinsons Disease and L-DOPA induced dyskinesia. Abstract from OAK Meeting, København, Denmark.
Landau, A., Yashpal, K., Cahill, C. M., St Louis, M., Ribeiro-da-Silva, A. & Henry, J. L. (2007).
Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation.
Neuroscience,
145(2), 699-707.
https://doi.org/10.1016/j.neuroscience.2006.11.066
Hammers, A., Chen, C. H., Lemieux, L., Allom, R., Vossos, S., Free, S. L., Myers, R.
, Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007).
Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space.
Human Brain Mapping,
28(1), 34-48.
https://doi.org/10.1002/hbm.20254
Thobois, S., Hotton, G. R., Pinto, S., Wilkinson, L., Limousin-Dowsey, P.
, Brooks, D. J. & Jahanshahi, M. (2007).
STN stimulation alters pallidal-frontal coupling during response selection under competition.
Journal of Cerebral Blood Flow and Metabolism,
27(6), 1173-1184.
https://doi.org/10.1038/sj.jcbfm.9600425
Hammers, A., Asselin, M. C., Hinz, R., Kitchen, I.
, Brooks, D. J., Duncan, J. S. & Koepp, M. J. (2007).
Upregulation of opioid receptor binding following spontaneous epileptic seizures.
Brain,
130(4), 1009-1016.
https://doi.org/10.1093/brain/awm012
Ahsan, R. L., Allom, R., Gousias, I. S., Habib, H., Turkheimer, F. E., Free, S., Lemieux, L., Myers, R., Duncan, J. S.
, Brooks, D. J., Koepp, M. J. & Hammers, A. (2007).
Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus.
NeuroImage,
38(2), 261-270.
https://doi.org/10.1016/j.neuroimage.2007.06.004
Turner, M. R., Hammers, A., Allsop, J., Al-Chalabi, A., Shaw, C.
, Brooks, D. J., Leigh, N. P.
& Andersen, P. (2007).
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis,
8(6), 343-347.
https://doi.org/10.1080/17482960701538734
Pedersen, K., Simonsen, M., Østergaard, S.
, Munk, O. L., Møller, A., Rosa-Neto, P.
, Olsen, A. K., Jensen, S. B. & Cumming, P. (2007).
Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: Modulation by MAO-inhibition.
NeuroImage.
Archer, H. A., Edison, P.
, Brooks, D. J., Barnes, J., Frost, C., Yeatman, T., Fox, N. C. & Rossor, M. N. (2006).
Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C-PIB positron emission tomography study.
Annals of Neurology,
60(1), 145-147.
https://doi.org/10.1002/ana.20889
Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G.
, Brooks, D. J., Lees, A. J. & Piccini, P. (2006).
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study.
Neurology,
67(9), 1612-1617.
https://doi.org/10.1212/01.wnl.0000242888.30755.5d
Evans, A. H.
, Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M.
, Brooks, D. J., Lees, A. J. & Piccini, P. (2006).
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Annals of Neurology,
59(5), 852-858.
https://doi.org/10.1002/ana.20822
Møller, A., Callesen, M. B., Thomsen, K. R.
, Gjedde, A. & Linnet, J. (2006).
Den spilreducerende spilleautomat. Poster session presented at Forskningens Dag, Århus, Denmark.
Rascol, O.
, Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., Lang, A. E., Abdalla, M., Harmant, J., Jacquy, J., King, D., Martin, W., Destee, A., Durif, F., Aharon-Peretz, J., Reches, A., Bergamasco, B., Bracco, F., Frattolla, L., Nordera, P. ... Wroe, S. V. (2006).
Development of dyskinesias in a 5-year trial and ropinirole and L-dopa.
Movement Disorders,
21(11), 1844-1850.
https://doi.org/10.1002/mds.20988
Goerendt, I. K., Lawrence, A. D., Mehta, M. A., Stern, J. S., Odin, P.
& Brooks, D. J. (2006).
Distributed neural actions of anti-parkinsonian therapies as revealed by PET.
Journal of Neural Transmission,
113(1), 75-86.
https://doi.org/10.1007/s00702-005-0305-5
Peterson, E.
, Gjedde, A., Rodell, A., Cumming, P., Møller, A. & Linnet, J. (2006).
Dopamine receptor availability linked to dopamine occupancy during gambling. Poster session presented at 6th Neuroreceptor Mapping Symposium, Copenhagen, Denmark.
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R.
, Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G. F., Elias, W. J. ... Traub, M. (2006).
Erratum: Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease (Annals of Neurology (2006) 59 (459-466)).
Annals of Neurology,
60(6).
https://doi.org/10.1002/ana.21061
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M.
, Brooks, D. J., Svendsen, C. N. & Heywood, P. (2006).
Erratum: ADDENDUM: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (Nature Medicine (2003) 9 (589-595)).
Nature Medicine,
12(4).
https://doi.org/10.1038/nm0406-479
Husum, H., Aznar, S., Hoyer-Hansen, S., Larsen, M. H.
, Møller, A., Malthe, A. A. & Worthwein, G. (2006).
Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IP fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: Implications for the pathophysiology of depression? J Neurosci Res.,
84(6), 1292-1302.
Peterson, E.
, Gjedde, A., Rodell, A., Cumming, P., Møller, A. & Linnet, J. (2006).
High sensation seeking men have increased dopamine binding in the right putamen determined from raclopride binding potentials. Poster session presented at 7th Annual Conference on Gambling and Addiction, Las Vegas, United States.
Linnet, J., Gjedde, A., Kumakura, Y.
, Cumming, P. & Møller, A. (2006).
Hvad sker der i hjernen, når man spiller?. Poster session presented at Forskningens Døgn, Aarhus, Denmark.
Gerhard, A., Trender-Gerhard, I., Turkheimer, F., Quinn, N. P., Bhatia, K. P.
& Brooks, D. J. (2006).
In vivo imaging of microglial activation with [11C]-PK11195 PET progresive supranuclear palsy.
Movement Disorders,
21(1), 89-93.
https://doi.org/10.1002/mds.20668
Gerhard, A.
, Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B.
& Brooks, D. J. (2006).
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Neurobiology of Disease,
21(2), 404-412.
https://doi.org/10.1016/j.nbd.2005.08.002
Linnet, J., Peterson, E.
, Bailey, C., Gjedde, A. & Møller, A. (2006).
Kliniske. psykologiske og neurobiologiske aspekter af kønsforskelle indenfor ludomani. Poster session presented at Forskningens Dag, Århus, Denmark.
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A.
, Brooks, D. J. & Piccini, P. (2006).
Microglial activation correlates with severity in Huntington disease: A clinical and PET study.
Neurology,
66(11), 1638-1643.
https://doi.org/10.1212/01.wnl.0000222734.56412.17
Hu, M. T. M., Scherfler, C., Khan, N. L., Hajnal, J. V., Lees, A. J., Quinn, N., Wood, N. W.
& Brooks, D. J. (2006).
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease.
Movement Disorders,
21(3), 299-305.
https://doi.org/10.1002/mds.20702
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R.
, Brooks, D. J., Hotton, G., Moro, E., Heywood, P., Brodsky, M. A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V. G. F., Elias, W. J. ... Traub, M. (2006).
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Annals of Neurology,
59(3), 459-466.
https://doi.org/10.1002/ana.20737
Piccini, P.
, Pavese, N., Hagell, P.
, Reimer, J., Bjorklund, A., Oertel, W. H., Quinn, N. P.
, Brooks, D. J. & Lindvall, O. (2006).
Reply: Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease [2].
Brain,
129(7).
https://doi.org/10.1093/brain/awl113
Scherfler, C., Khan, N. L.
, Pavese, N., Lees, A. J., Quinn, N. P.
, Brooks, D. J. & Piccini, P. P. (2006).
Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
Movement Disorders,
21(6), 783-788.
https://doi.org/10.1002/mds.20811
Turner, M. R., Osei-Lah, A. D., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J., Leigh, P. N. & Mills, K. R. (2005).
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
Journal of Neurology, Neurosurgery & Psychiatry,
76(9), 1279-1285.
https://doi.org/10.1136/jnnp.2004.054429
Isaacs, J. D., Rakshi, J., Baker, R.
, Brooks, D. J. & Warrens, A. N. (2005).
Chorea associated with thyroxine replacement therapy.
Movement Disorders,
20(12), 1656-1657.
https://doi.org/10.1002/mds.20603
Landau, A., Luk, K. C., Jones, M.-L., Siegrist-Johnstone, R., Young, Y. K., Kouassi, E., Rymar, V. V., Dagher, A., Sadikot, A. F. & Desbarats, J. (2005).
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease.
Journal of Experimental Medicine,
202(5), 575-81.
https://doi.org/10.1084/jem.20050163
Remy, P., Doder, M., Lees, A., Turjanski, N.
& Brooks, D. (2005).
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system.
Brain,
128(6), 1314-1322.
https://doi.org/10.1093/brain/awh445
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2005).
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET.
Brain,
128(6), 1323-1329.
https://doi.org/10.1093/brain/awh509
Khan, N. L., Scherfler, C., Graham, E., Bhatia, K. P., Quinn, N., Lees, A. J.
, Brooks, D. J., Wood, N. W. & Piccini, P. (2005).
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Neurology,
64(1), 134-136.
https://doi.org/10.1212/01.WNL.0000148725.48740.6D
Piccini, P.
, Pavese, N., Hagell, P., Reimer, J., Björklund, A., Oertel, W. H., Quinn, N. P.
, Brooks, D. J. & Lindvall, O. (2005).
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Brain,
128(12), 2977-2986.
https://doi.org/10.1093/brain/awh649
Lingford-Hughes, A. R., Wilson, S. J., Cunningham, V. J., Feeney, A., Stevenson, B.
, Brooks, D. J. & Nutt, D. J. (2005).
GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study.
Psychopharmacology,
180(4), 595-606.
https://doi.org/10.1007/s00213-005-2271-x
Ros, R., Garre, P. G., Hirano, M., Tai, Y. F., Ampuero, I., Vidal, L., Rojo, A., Fontan, A., Vazquez, A., Fanjul, S., Hernandez, J., Cantarero, S., Hoenicka, J., Jones, A., Ahsan, R. L.
, Pavese, N., Piccini, P.
, Brooks, D. J., Perez-Tur, J. ... De Yébenes, J. G. (2005).
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.
Annals of Neurology,
57(5), 634-641.
https://doi.org/10.1002/ana.20449
Love, S., Plaha, P., Patel, N. K., Hotton, G. R.
, Brooks, D. J. & Gill, S. S. (2005).
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.
Nature Medicine,
11(7), 703-704.
https://doi.org/10.1038/nm0705-703
Linnet, J., Gjedde, A., Kumakura, Y.
, Cumming, P. & Møller, A. (2005).
High sensation seeking men have increased dopamine release in the right putamen during gambling. Poster session presented at High sensation seeking men have increased dopamine release in the right putamen during gambling, Washington DC, United States.
Cheesman, A. L., Barker, R. A., Lewis, S. J. G., Robbins, T. W., Owen, A. M.
& Brooks, D. J. (2005).
Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease.
Journal of Neurology, Neurosurgery & Psychiatry,
76(9), 1204-1210.
https://doi.org/10.1136/jnnp.2004.055079
Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C.
& Brooks, D. J. (2005).
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases.
Journal of Neurology, Neurosurgery & Psychiatry,
76(1), 115-117.
https://doi.org/10.1136/jnnp.2004.046292
Turner, M. R., Gerhard, A., Al-Chalabi, A., Shaw, C. E., Hughes, R. A. C., Banati, R. B.
, Brooks, D. J. & Leigh, P. N. (2005).
Mills' and other isolated upper motor neurone syndromes: In vivo study with 11C-(R)-PK11195 PET.
Journal of Neurology, Neurosurgery & Psychiatry,
76(6), 871-874.
https://doi.org/10.1136/jnnp.2004.047902
Khan, N. L., Jain, S., Lynch, J. M.
, Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., Gibbons, V., Gandhi, S., Vaughan, J., Eunson, L. H., Katzenschlager, R., Gayton, J., Lennox, G., Revesz, T., Nicholl, D. ... Wood, N. W. (2005).
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: Clinical, pathological, olfactory and functional imaging and genetic data.
Brain,
128(12), 2786-2796.
https://doi.org/10.1093/brain/awh667
Rascol, O.
, Brooks, D. J., Melamed, E., Oertel, W., Poewe, W., Stocchi, F. & Tolosa, E. (2005).
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial.
Lancet,
365(9463), 947-954.
https://doi.org/10.1016/S0140-6736(05)71083-7
Turner, M. R., Rabiner, E. A., Hammers, A., Al-Chalabi, A., Grasby, P. M., Shaw, C. E.
, Brooks, D. J. & Leigh, P. N. (2005).
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.
Brain,
128(4), 896-905.
https://doi.org/10.1093/brain/awh428
Von Spiczak, S., Whone, A. L., Hammers, A., Asselin, M. C., Turkheimer, F., Tings, T., Happe, S., Paulus, W., Trenkwalder, C.
& Brooks, D. J. (2005).
The role of opioids in restless legs syndrome: An [11C] diprenorphine PET study.
Brain,
128(4), 906-917.
https://doi.org/10.1093/brain/awh441
Ravina, B., Eidelberg, D., Ahlskog, J. E., Albin, R. L.
, Brooks, D. J., Carbon, M., Dhawan, V., Feigin, A., Fahn, S., Guttman, M., Gwinn-Hardy, K., McFarland, H., Innis, R., Katz, R. G., Kieburtz, K., Kish, S. J., Lange, N., Langston, J. W., Marek, K. ... Holloway, R. (2005).
The role of radiotracer imaging in Parkinson disease.
Neurology,
64(2), 208-215.
https://doi.org/10.1212/01.WNL.0000149403.14458.7F
Brooks, D. J., Agid, Y., Eggert, K., Widner, H.
, Østergaard, K. & Holopainen, A. (2005).
Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo® (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess®/Comtan® (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
European Neurology,
53(4), 197-202.
https://doi.org/10.1159/000086479
Melichar, J. K., Hume, S. P., Williams, T. M., Daglish, M. R. C., Taylor, L. G., Ahmad, R., Malizia, A. L.
, Brooks, D. J., Myles, J. S., Lingford-Hughes, A. & Nutt, D. J. (2005).
Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies.
Journal of Pharmacology and Experimental Therapeutics,
312(1), 309-315.
https://doi.org/10.1124/jpet.104.072686
Whone, A. L., Bailey, D. L., Remy, P.
, Pavese, N. & Brooks, D. J. (2004).
A technique for standardized central analysis of 6-18F-fluoro-L- DOPA PET data from a multicenter study.
Journal of Nuclear Medicine,
45(7), 1135-1145.
Pavese, N., Rimoldi, O., Gerhard, A.
, Brooks, D. J. & Piccini, P. (2004).
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Movement Disorders,
19(3), 298-303.
https://doi.org/10.1002/mds.10651
Wenning, G. K., Tison, F., Seppi, K., Sampiao, C., Diem, A., Yekhlef, F., Ghorayeb, I., Ory, F., Galitzky, M., Scaravilli, T., Bozi, M., Colosimo, C., Gilman, S., Shults, C. W., Quinn, N. P., Rascol, O., Poewe, W.
, Dupont, E., Ostergaard, K. ... Bergquist, J. (2004).
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Movement Disorders,
19(12), 1391-1402.
https://doi.org/10.1002/mds.20255
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E.
, Brooks, D. J., Leigh, P. N. & Banati, R. B. (2004).
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study.
Neurobiology of Disease,
15(3), 601-609.
https://doi.org/10.1016/j.nbd.2003.12.012
Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K.
& Brooks, D. J. (2004).
In vivo imaging of microglial activation with [11C](R -PK11195 PET in corticobasal degeneration.
Movement Disorders,
19(10), 1221-1226.
https://doi.org/10.1002/mds.20162
Whone, A. L., Von Spiczak, S., Edwards, M., Valente, E. M., Hammers, A., Bhatia, K. P.
& Brooks, D. J. (2004).
Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study.
Movement Disorders,
19(12), 1498-1503.
https://doi.org/10.1002/mds.20238
Scherfler, C.
, Khan, N. L., Pavese, N., Eunson, L., Graham, E., Lees, A. J., Quinn, N. P., Wood, N. W.
, Brooks, D. J. & Piccini, P. P. (2004).
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Brain,
127(6), 1332-1342.
https://doi.org/10.1093/brain/awh150
Tai, Y. F., Scherfler, C.
, Brooks, D. J., Sawamoto, N. & Castiello, U. (2004).
The Human Premotor Cortex Is 'Mirror' only for Biological Actions.
Current Biology,
14(2), 117-120.
https://doi.org/10.1016/j.cub.2004.01.005
Brooks, D. J., Frey, K. A., Marek, K. L., Oakes, D., Paty, D., Prentice, R., Shults, C. W. & Stoessl, A. J. (2003).
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental Neurology,
184(SUPPL. 1).
https://doi.org/10.1016/j.expneurol.2003.08.008
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M.
, Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003).
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Nature Medicine,
9(5), 589-595.
https://doi.org/10.1038/nm850
Goerendt, I. K., Messa, C., Lawrence, A. D., Grasby, P. M., Piccini, P.
& Brooks, D. J. (2003).
Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study.
Brain,
126(2), 312-325.
https://doi.org/10.1093/brain/awg035
Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R.
, Brooks, D. J. & Duncan, J. S. (2003).
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients.
Brain,
126(6), 1300-1318.
https://doi.org/10.1093/brain/awg138
Pavese, N., Andrews, T. C.
, Brooks, D. J., Ho, A. K., Rosser, A. E., Barker, R. A., Robbins, T. W., Sahakian, B. J., Dunnett, S. B. & Piccini, P. (2003).
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A pet study.
Brain,
126(5), 1127-1135.
https://doi.org/10.1093/brain/awg119
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O.
, Ribeiro, M. J., Remy, P., Poewe, W. H., Hauser, R. A.
& Brooks, D. J. (2003).
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of Neurology,
54(1), 93-101.
https://doi.org/10.1002/ana.10609
Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N.
, Schwarz, J. & Brooks, D. J. (2003).
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
Neurology,
61(5), 686-689.
https://doi.org/10.1212/01.WNL.0000078192.95645.E6
Berding, G., Brücke, T., Odin, P.
, Brooks, D. J., Kolbe, H., Gielow, P., Harke, H., Knoop, B. O., Dengler, R. & Knapp, W. H. (2003).
[123I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Nuklearmedizin,
42(1), 31-38.
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N.
, Brooks, D. J. & Duncan, J. S. (2003).
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.
Human Brain Mapping,
19(4), 224-247.
https://doi.org/10.1002/hbm.10123
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J.
& Brooks, D. J. (2003).
Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study.
Neurology,
60(4), 601-605.
https://doi.org/10.1212/01.WNL.0000031424.51127.2B
Ceravolo, R., Piccini, P., Bailey, D. L., Jorga, K. M., Bryson, H.
& Brooks, D. J. (2002).
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Synapse,
43(3), 201-207.
https://doi.org/10.1002/syn.10034
Hammers, A., Koepp, M. J., Hurlemann, R., Thom, M., Richardson, M. P.
, Brooks, D. J. & Duncan, J. S. (2002).
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Brain,
125(10), 2257-2271.
https://doi.org/10.1093/brain/awf233
Rakshi, J. S.
, Pavese, N., Uema, T.
, Ito, K., Morrish, P. K., Bailey, D. L.
& Brooks, D. J. (2002).
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study.
Journal of Neural Transmission,
109(12), 1433-1443.
https://doi.org/10.1007/s00702-002-0753-0
Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Dagher, A., Forster, K., Haslinger, B.
, Brooks, D. J., Schwaiger, M. & Conrad, B. (2002).
A H2 15O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction.
NeuroImage,
17(2), 999-1009.
https://doi.org/10.1016/S1053-8119(02)91139-0
Hu, M. T. M., Chaudhuri, K. R., Jorosz, J., Yaguez, L.
& Brooks, D. J. (2002).
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Movement Disorders,
17(6), 1321-1328.
https://doi.org/10.1002/mds.10261
Brunt, E. R.
, Brooks, D. J., Korczyn, A. D., Montastruc, J. L. & Stocchi, F. (2002).
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of Neural Transmission,
109(4), 489-502.
https://doi.org/10.1007/s007020200040
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A.
, Brooks, D. J. & Piccini, P. (2002).
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study.
Annals of Neurology,
52(6), 849-853.
https://doi.org/10.1002/ana.10417
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L.
, Pavese, N., Oertel, W. H., Quinn, N.
, Brooks, D. J. & Lindvall, O. (2002).
Dyskinesias following neural transplantation in parkinson’s disease.
Nature Neuroscience,
5(7), 627-628.
https://doi.org/10.1038/nn863
Johansen, J., Rosenblad, C., Andsberg, K.
, Møller, A., Lundberg, C., Björlund, A. & Johansen, TE. (2002).
Evaluation on Tet-on system to avoid transgene downregulation in ex vivo gene transfer to the CNS.
Gene Therapy,
9, 1291-1301.
Leigh, P. N., Simmons, A., Williams, S., Williams, V., Turner, M.
& Brooks, D. (2002).
Imaging: MRS/MRI/PET/SPECT: Summary.
Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders,
3(SUPPL. 1).
Lingford-Hughes, A., Hume, S. P., Feeney, A., Hirani, E., Osman, S., Cunningham, V. J., Pike, V. W.
, Brooks, D. J. & Nutt, D. J. (2002).
Imaging the GABA-benzodiazepine receptor subtype containing the α-5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
22(7), 878-889.
https://doi.org/10.1097/00004647-200207000-00013
Hammers, A., Koepp, M. J., Free, S. L., Brett, M., Richardson, M. P., Labbé, C., Cunningham, V. J.
, Brooks, D. J. & Duncan, J. (2002).
Implementation and application of a brain template for multiple volumes of interest.
Human Brain Mapping,
15(3), 165-174.
https://doi.org/10.1002/hbm.10016
Kjaer, T. W.
, Bertelsen, C., Piccini, P.
, Brooks, D., Alving, J. & Lou, H. C. (2002).
Increased dopamine tone during meditation-induced change of consciousness.
Cognitive Brain Research,
13(2), 255-259.
https://doi.org/10.1016/S0926-6410(01)00106-9
Dagø, L., Bonde, C., Peters, D.
, Møller, A., Bomholt, S. F., Hartz, B. P., Meyer, M., Drejer, J. & Grønborg, M. (2002).
NS1231, a novel compound with neurotrophic-like effects in vitro and in vivo.
Neurochemical,
81, 17-24.
Khan, N. L., Brooks, D. J., Pavese, N., Sweeney, M. G., Wood, N. W., Lees, A. J. & Piccini, P. (2002).
Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study.
Brain,
125(10), 2248-2256.
Dall, A. M.
, Danielsen, E. H., Sørensen, J. C. H., Andersen, F., Møller, A., Zimmer, J.
, Gjedde, A. H. & Cumming, P. (2002).
Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation,
11(8), 733-46.
Dall, A. M., Danielsen, E. H., Sørensen, J. C., Andersen, F.
, Møller, A., Zimmer, J., Gjedde, A., the DaNeX Group & Cumming, P. (2002).
Quantitative [18F]Fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned Minipigs.
Cell Transplantation,
11, 733-746.
Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Abe, Y., Yamada, T., Kachi, T.
& Brooks, D. J. (2002).
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study.
Brain,
125(6), 1358-1365.
https://doi.org/10.1093/brain/awf134
Nicholl, D. J., Vaughan, J. R.
, Khan, N. L., Ho, S. L., Aldous, D. E. W., Lincoln, S., Farrer, M., Gayton, J. D.
, Davis, M. B., Piccini, P., Daniel, S. E., Lennox, G. G.
, Brooks, D. J., Williams, A. C. & Wood, N. W. (2002).
Two large British kindreds with familial Parkinson's disease: A clinico-pathological and genetic study.
Brain,
125(1), 44-57.
https://doi.org/10.1093/brain/awf013
Hu, M. T. M., White, S. J., Herlihy, A. H., Chaudhuri, K. R., Hajnal, J. V.
& Brooks, D. J. (2001).
A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease.
Neurology,
56(9), 1195-1200.
https://doi.org/10.1212/WNL.56.9.1195
Hammers, A., Koepp, M. J., Richardson, M. P., Labbé, C.
, Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (2001).
Central benzodiazepine receptors in malformations of cortical development: A quantitative study.
Brain,
124(8), 1555-1565.
Hu, M. T. M., White, S. J., Chaudhuri, K. R., Morris, R. G., Bydder, G. M.
& Brooks, D. J. (2001).
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.
Journal of Neural Transmission,
108(5), 571-580.
https://doi.org/10.1007/s007020170057
Hirani, E., Gillies, J., Karasawa, A., Shimada, J., Kase, H., Opacka-Juffry, J.
, Osman, S., Luthra, S. K., Hume, S. P.
& Brooks, D. J. (2001).
Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats.
Synapse,
42(3), 164-176.
https://doi.org/10.1002/syn.1110
Sager, T. N., Topp, S., Torup, L., Egestad, B.
& Møller, A. (2001).
Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Research,
892, 166-175.
Piccini, P., De Yebenez, J., Lees, A. J., Ceravolo, R., Turjanski, N., Pramstaller, P.
& Brooks, D. J. (2001).
Familial progressive supranuclear palsy: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Archives of Neurology,
58(11), 1846-1851.
https://doi.org/10.1001/archneur.58.11.1846
Del Dotto, P.
, Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N. & Bonuccelli, U. (2001).
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study.
Movement Disorders,
16(3), 515-520.
https://doi.org/10.1002/mds.1112
Cagnin, A.
, Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T. & Banati, R. B. (2001).
In-vivo measurement of activated microglia in dementia.
Lancet,
358(9280), 461-467.
https://doi.org/10.1016/S0140-6736(01)05625-2
Banati, R. B., Cagnin, A.
, Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R. & Anand, P. (2001).
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury.
NeuroReport,
12(16), 3439-3442.
https://doi.org/10.1097/00001756-200111160-00012
Hammers, A., Koepp, M. J., Labbé, C.
, Brooks, D. J., Thom, M., Cunningham, V. J. & Duncan, J. S. (2001).
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy.
Neurology,
56(7), 897-906.
https://doi.org/10.1212/WNL.56.7.897
Cumming, P., Danielsen, E. H., Vafaee, M., Faldborg, L., Steffensen, E., Sørensen, J. C., Gillings, N., Bender, D., Marthi, K., Andersen, F., Munk, O., Smith, D.
, Møller, A. & Gjedde, A. (2001).
Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts.
Acta Neurologica Scandinavica,
103, 309-315.
Varming, T., Sager, T. N., Mathiesen, C., Johansen, T. H.
, Møller, A., Wätjen, F. & Drejer, J. (2001).
Optimazation of isatine oximes as neuroprotective AMPA receptor antagonist: In vitro and in vivo evaluation of SPD 502. In: Excitatory amino acids: Ten years after.
IOS press.
Berding, G., Odin, P.
, Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R., Samii, M. & Knapp, W. H. (2001).
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET.
Movement Disorders,
16(6), 1014-1022.
https://doi.org/10.1002/mds.1212
Carboncini, M. C., Manzoni, D., Strambi, S., Bonuccelli, U.
, Pavese, N., Andre, P. & Rossi, B. (2001).
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia.
Movement Disorders,
16(1), 47-57.
https://doi.org/10.1002/1531-8257(200101)16:1<47::AID-MDS1012>3.0.CO;2-V
Bhatia, K.
, Brooks, D. J., Burn, D. J., Clarke, C. E., Grosset, D. G., MacMahon, D. G., Fer, J. P., Schapira, A. H. V., Stewart, D. & Williams, A. C. (2001).
Updated guidelines for the management of Parlcinson's disease.
Hospital Medicine,
62(8), 456-470.
https://doi.org/10.12968/hosp.2001.62.8.1621
Rascol, O.
, Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E. & Lang, A. E. (2000).
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
New England Journal of Medicine,
342(20), 1484-1491.
https://doi.org/10.1056/NEJM200005183422004
Rønn, L. C. B., Ralets, I., Hartz, B. P., Bech, M., Berezin, A., Berezin, V.
, Møller, A. & Bock, E. (2000).
A simple procedure for quantification of neurite outgrowth based on stereological principles.
Journal of Neuroscience Methods,
100, 25-32.
Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Björklund, A.
, Brooks, D. J., Marsden, C. D., Oertel, W. H., Quinn, N. P., Rehncrona, S. & Lindvall, O. (2000).
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain,
123(7), 1380-1390.
Rogers, R. D., Andrews, T. C., Grasby, P. M.
, Brooks, D. J. & Robbins, T. W. (2000).
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans.
Journal of Cognitive Neuroscience,
12(1), 142-162.
https://doi.org/10.1162/089892900561931
Hu, M. T. M., Taylor-Robinson, S. D., Chaudhuri, K. R., Bell, J. D., Labbé, C., Cunningham, V. J., Koepp, M. J., Hammers, A., Morris, R. G., Turjanski, N.
& Brooks, D. J. (2000).
Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study.
Brain,
123(2), 340-352.
https://doi.org/10.1093/brain/123.2.340
Piccini, P., Lindvall, O., Björklund, A., Brundin, P., Hagell, P., Ceravolo, R., Oertel, W., Quinn, N., Samuel, M., Rehncrona, S., Widner, H.
& Brooks, D. J. (2000).
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts.
Annals of Neurology,
48(5), 689-695.
https://doi.org/10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N
Lloyd, C. M., Richardson, M. P.
, Brooks, D. J., Al-Chalabi, A. & Leigh, P. N. (2000).
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil.
Brain,
123(11), 2289-2296.
https://doi.org/10.1093/brain/123.11.2289
Hagell, P., Crabb, L., Pogarell, O., Schrag, A., Widner, H.
, Brooks, D. J., Oertel, W. H., Quinn, N. P. & Lindvall, O. (2000).
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
Movement Disorders,
15(2), 224-229.
https://doi.org/10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W
Jalan, R., Turjanski, N., Taylor-Robinson, S. D., Koepp, M. J., Richardson, M. P.
, Wilson, J. A., Bell, J. D.
& Brooks, D. J. (2000).
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis.
Gut,
46(4), 546-552.
https://doi.org/10.1136/gut.46.4.546
Reuter, I., Hu, M. T. M., Andrews, T. C.
, Brooks, D. J., Clough, C. & Ray Chaudhuri, K. (2000).
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
Journal of Neurology Neurosurgery and Psychiatry,
68(2), 238-241.
https://doi.org/10.1136/jnnp.68.2.238
Banati, R. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F. E.
, Brooks, D. J. & Jones, T. (2000).
Microglial activation in neurodegenerative diseases: A PET study using [11C](R)-PK11195.
NeuroImage,
11(6 PART II).
Pavese, N., Giannaccini, G., Betti, L., Ferrari, S., Bonanni, E., Bonuccelli, U., Murri, L. & Lucacchini, A. (2000).
Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura.
Neurochemistry International,
37(4), 363-368.
https://doi.org/10.1016/S0197-0186(00)00039-5
Jenkins, I. H., Jahanshahi, M., Jueptner, M., Passingham, R. E.
& Brooks, D. J. (2000).
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow.
Brain,
123(6), 1216-1228.
https://doi.org/10.1093/brain/123.6.1216
Koepp, M. J., Hammers, A., Labbé, C., Woermann, F. G.
, Brooks, D. J. & Duncan, J. S. (2000).
11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Neurology,
54(2), 332-339.
Piccini, P.
, Brooks, D. J., Korpela, K.
, Pavese, N., Karlsson, M. & Gordin, A. (2000).
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease.
Journal of Neurology Neurosurgery and Psychiatry,
68(5), 589-594.
https://doi.org/10.1136/jnnp.68.5.589
Danielsen, E. H., Cumming, P., Andersen, F.
, Bender, D., Brevig, T., Falborg, L., Gee, A., Gillings, N. M., Hansen, S. B., Hermansen, F., Johansen, J., Johansen, T. E., Dahl-Jørgensen, A., Jørgensen, H. A., Meyer, M.
, Munk, O. L., Pedersen, E. B., Poulsen, P. H., Rodell, A. B.
... Møller, A. (2000).
The DaNeX Study of Embryonic Mesencephalic Dopaminergic Tissue Grafted to a Minipig model of Parkinson's disease: Preliminary Findings of Effect of MPTP-Poisoning on Striatal Dopaminergic Markers.
Cell Transplantation,
9(2), 247-259.
White, R. P., Deane, C., Hindley, C., Bloomfield, P. M., Cunningham, V. J., Vallance, P.
, Brooks, D. J. & Markus, H. S. (2000).
The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man.
Journal of the Neurological Sciences,
178(1), 23-28.
https://doi.org/10.1016/S0022-510X(00)00357-9
Taylor-Robinson, S. D., Turjanski, N., Bhattacharya, S., Seery, J. P., Sargentoni, J.
, Brooks, D. J., Bryant, D. J. & Cox, I. J. (1999).
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Metabolic Brain Disease,
14(1), 45-55.
https://doi.org/10.1023/A:1020609530444
Nicolson, R. I., Fawcett, A. J., Berry, E. L., Jenkins, I. H., Dean, P.
& Brooks, D. J. (1999).
Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults.
Lancet,
353(9165), 1662-1667.
https://doi.org/10.1016/S0140-6736(98)09165-X
Pavese, N., Napolitano, A., De Laco, G., Canapicchi, R., Collavoli, P. L., Lucetti, C., Gambaccini, G. & Bonuccelli, U. (1999).
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study.
Italian Journal of Neurological Sciences,
20(3), 171-178.
https://doi.org/10.1007/s100720050028
Piccini, P.
, Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., Brundin, P., Hagell, P., Rehncrona, S., Widner, H. & Lindvall, O. (1999).
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Nature Neuroscience,
2(12), 1137-1140.
https://doi.org/10.1038/16060
Hu, M. T. M., Taylor-Robinson, S. D., Ray Chaudhuri, K., Bell, J. D., Morris, R. G., Clough, C.
, Brooks, D. J. & Turjanski, N. (1999).
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study.
Journal of Neurology Neurosurgery and Psychiatry,
67(1), 20-26.
https://doi.org/10.1136/jnnp.67.1.20
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J.
& Brooks, D. J. (1999).
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [18F]dopa-PET study.
Brain,
122(9), 1637-1650.
https://doi.org/10.1093/brain/122.9.1637
Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H. A., Sahakian, B., Hodges, J. R., Rosser, A. E., Wood, N. W.
& Brooks, D. J. (1999).
Huntington's disease progression. PET and clinical observations.
Brain,
122(12), 2353-2363.
https://doi.org/10.1093/brain/122.12.2353
Hamdy, S., Rothwell, J. C.
, Brooks, D. J., Bailey, D., Aziz, Q. & Thompson, D. G. (1999).
Identification of the cerebral loci processing human swallowing with H2 15O PET activation.
Journal of Neurophysiology,
81(4), 1917-1926.
https://doi.org/10.1152/jn.1999.81.4.1917